Cite
HARVARD Citation
Stattin, M. et al. (2019). Five‐year outcomes of a personalized pro re nata treatment regimen with anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration. Acta ophthalmologica. 97 (1), pp. e131-e133. [Online].